mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal new junction evidence (sorted from low to high skew) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913 | = 3640591 | 114 (1.080) | 3 (0.030) | 3/386 | NT | 2.8% | intergenic (+46/‑271) | uspA/dtpB | universal stress global response regulator/dipeptide and tripeptide permease B |
| ? | NC_000913 | = 3640569 | 108 (1.140) | intergenic (+24/‑293) | uspA/dtpB | universal stress global response regulator/dipeptide and tripeptide permease B | |||||
| * | ? | NC_000913 | 3515982 = | 144 (1.360) | 6 (0.060) | 6/412 | NT | 4.5% | intergenic (‑69/+38) | dam/damX | DNA adenine methyltransferase/cell division protein that binds to the septal ring |
| ? | NC_000913 | 3516010 = | 119 (1.180) | intergenic (‑97/+10) | dam/damX | DNA adenine methyltransferase/cell division protein that binds to the septal ring | |||||
| * | ? | NC_000913 | = 3382372 | 108 (1.020) | 4 (0.040) | 4/424 | NT | 3.6% | coding (173/1068 nt) | degS | serine endoprotease, periplasmic |
| ? | NC_000913 | 3382376 = | 107 (1.030) | coding (177/1068 nt) | degS | serine endoprotease, periplasmic | |||||
| * | ? | NC_000913 | 2596863 = | 75 (0.710) | 3 (0.030) | 3/408 | NT | 4.0% | intergenic (‑126/+42) | ypfJ/purC | putative neutral zinc metallopeptidase/phosphoribosylaminoimidazole‑succinocarboxamide synthetase |
| ? | NC_000913 | 2596890 = | 72 (0.720) | intergenic (‑153/+15) | ypfJ/purC | putative neutral zinc metallopeptidase/phosphoribosylaminoimidazole‑succinocarboxamide synthetase | |||||
| * | ? | NC_000913 | = 2592988 | 127 (1.200) | 5 (0.050) | 4/416 | NT | 3.9% | noncoding (11/83 nt) | REP180 (repetitive extragenic palindromic) element; contains 2 REP sequences | REP180 (repetitive extragenic palindromic) element; contains 2 REP sequences |
| ? | NC_000913 | = 2593004 | 125 (1.220) | noncoding (27/83 nt) | REP180 (repetitive extragenic palindromic) element; contains 2 REP sequences | REP180 (repetitive extragenic palindromic) element; contains 2 REP sequences | |||||
| * | ? | NC_000913 | = 2515616 | NA (NA) | 3 (0.030) | 3/426 | NT | 2.9% | noncoding (1344/1345 nt) | IS186 | repeat region |
| ? | NC_000913 | 2536312 = | 102 (0.970) | coding (479/510 nt) | crr | glucose‑specific enzyme IIA component of PTS | |||||
| * | ? | NC_000913 | = 2397716 | 91 (0.860) | 3 (0.030) | 3/424 | NT | 3.2% | coding (2450/2727 nt) | nuoG | NADH:ubiquinone oxidoreductase, chain G |
| ? | NC_000913 | 2397720 = | 91 (0.870) | coding (2446/2727 nt) | nuoG | NADH:ubiquinone oxidoreductase, chain G | |||||
| * | ? | NC_000913 | = 1269636 | 87 (0.820) | 3 (0.030) | 3/412 | NT | 3.0% | intergenic (+247/+67) | rdlA/ldrB | sRNA antisense regulator affects LdrA translation; proposed addiction module in LDR‑A repeat, with toxic peptide LdrA/toxic polypeptide, small |
| ? | NC_000913 | = 1270179 | 110 (1.090) | intergenic (+256/+59) | rdlB/ldrC | sRNA antisense regulator affects LdrB translation; proposed addiction module in LDR‑B repeat, with toxic peptide LdrB/toxic polypeptide, small | |||||
| * | ? | NC_000913 | 626689 = | 109 (1.030) | 3 (0.030) | 3/414 | NT | 2.7% | coding (620/1611 nt) | entE | 2,3‑dihydroxybenzoate‑AMP ligase component of enterobactin synthase multienzyme complex |
| ? | NC_000913 | = 626685 | 108 (1.060) | coding (616/1611 nt) | entE | 2,3‑dihydroxybenzoate‑AMP ligase component of enterobactin synthase multienzyme complex | |||||